Hugues Abriel studied life sciences at the Swiss Federal Institute of Technology in Zurich (ETHZ, 1989) and medicine at the University of Lausanne in Switzerland (MD, 1994). He received a Ph.D. degree in Physiology from the University of Lausanne (1995). He has spent two years as a research scientist at Columbia University in New York, USA. Hugues Abriel has been a Group Leader (2002-2009) at the Department of Pharmacology and Toxicology at the University of Lausanne thanks to a professorship from the Swiss National Science Foundation (SNSF-Professor). From 2009 until 2016, he was the Director of the Department of Clinical Research (now Department
Since October 2016, he is one of the Co-Directors of the Institute of Biochemistry and Molecular Medicine at the University of Bern, as well as Professor of Molecular Medicine. From 2012 to 2020, he was one of the members of the Research Council of the SNSF. He chaired, as president, the division of Biology and Medicine from 2018 to 2020. He is the Director since 2015 of the SNSF-funded research network NCCR TransCure. His research work focuses on the roles of ion channels in human diseases (channelopathies). Currently, he is mainly exploring the genetic, molecular and cellular basis of cardiac arrhythmias.
Currently, Hugues Abriel is on an academic sabbatical leave.